These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 32151355)
21. PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3). Sorbye H; Kong G; Grozinsky-Glasberg S Endocr Relat Cancer; 2020 Mar; 27(3):R67-R77. PubMed ID: 31846429 [TBL] [Abstract][Full Text] [Related]
22. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas. Tang LH; Basturk O; Sue JJ; Klimstra DS Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015 [TBL] [Abstract][Full Text] [Related]
25. Management of advanced high grade gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): comprehensive review of the current literature. Mohamed A; Trybula M; Asa SL; Halfdanarson TR; Sonbol MB Endocr Relat Cancer; 2024 Oct; 31(10):. PubMed ID: 39133180 [TBL] [Abstract][Full Text] [Related]
26. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636 [TBL] [Abstract][Full Text] [Related]
27. Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary Tumor. Grillo F; Albertelli M; Brisigotti MP; Borra T; Boschetti M; Fiocca R; Ferone D; Mastracci L Neuroendocrinology; 2016; 103(5):452-9. PubMed ID: 26337010 [TBL] [Abstract][Full Text] [Related]
28. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study. Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205 [TBL] [Abstract][Full Text] [Related]
29. Recent updates on grading and classification of neuroendocrine tumors. Kim JY; Hong SM; Ro JY Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335 [TBL] [Abstract][Full Text] [Related]
30. Multivariate analysis of metastasis‑related risk factors for patients with gastroenteropancreatic neuroendocrine tumors based on clinicopathological and endoscopic features. Tang C; Gong L; Zou W; Zhang J; Zhou Y; Wu X; Lu F; Ouyang C; Liu X Oncol Rep; 2016 Dec; 36(6):3343-3352. PubMed ID: 27748940 [TBL] [Abstract][Full Text] [Related]
31. Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases. Estrozi B; Bacchi CE Clinics (Sao Paulo); 2011; 66(10):1671-5. PubMed ID: 22012036 [TBL] [Abstract][Full Text] [Related]
32. Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A. Roininen N; Takala S; Haapasaari KM; Jukkola-Vuorinen A; Mattson J; Heikkilä P; Karihtala P Oncology; 2019; 96(3):147-155. PubMed ID: 30282082 [TBL] [Abstract][Full Text] [Related]
33. Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study. Shi H; Zhang Q; Han C; Zhen D; Lin R BMC Endocr Disord; 2018 Jul; 18(1):51. PubMed ID: 30055596 [TBL] [Abstract][Full Text] [Related]
34. [Gastroenteropancreatic neuroendocrine tumors: what must the pathologist know and do in 2014?]. Scoazec JY; Couvelard A; Ann Pathol; 2014 Feb; 34(1):40-50. PubMed ID: 24630636 [TBL] [Abstract][Full Text] [Related]
36. [Histo- and molecular pathology in gastroenteropancreatic neuroendocrine neoplasms]. Kellers F; Schulte DM; Jesinghaus M; Konukiewitz B Dtsch Med Wochenschr; 2024 Aug; 149(15):887-893. PubMed ID: 39013409 [TBL] [Abstract][Full Text] [Related]
37. Gastroenteropancreatic grade 3 neuroendocrine tumors: a single entity or a heterogeneous group? A retrospective analysis. Laffi A; Spada F; Bagnardi V; Frassoni S; Pisa E; Rubino M; Barberis M; Fazio N J Endocrinol Invest; 2022 Feb; 45(2):317-325. PubMed ID: 34282554 [TBL] [Abstract][Full Text] [Related]
38. High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Improved Prognostic Stratification With the New World Health Organization 2019 Classification: A Validation Study From a Single-Institution Retrospective Analysis. Hayes AR; Furnace M; Shah R; Rundell C; Muller G; Dehbi HM; Luong TV; Toumpanakis C; Caplin ME; Krell D; Thirlwell C; Mandair D Pancreas; 2021 Apr; 50(4):516-523. PubMed ID: 33939663 [TBL] [Abstract][Full Text] [Related]
39. Models of Gastroenteropancreatic Neuroendocrine Neoplasms: Current Status and Future Directions. Detjen K; Hammerich L; Özdirik B; Demir M; Wiedenmann B; Tacke F; Jann H; Roderburg C Neuroendocrinology; 2021; 111(3):217-236. PubMed ID: 32615560 [TBL] [Abstract][Full Text] [Related]